DB, MD

Pharmaceutical Facts Investors Should Know

As a physician I can safely reply to CLH, that the theft is more often the other way around. Typically, the researchers at NIH will develop a compound, prove it works and then license it to a pharma company. Case in point look at the treatment of Gaucher's disease, yearly treatment cost over $100K, for a treatment developed by public research.